These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 24857216)
1. [Up-regulation of NKG2D ligand ULBP2 by matrine in K562 cells and the underlying molecular mechanisms]. Ma L; Zhu Z; Lu X; Jiang L; Zhou M; Qian S; Li J Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):438-42. PubMed ID: 24857216 [TBL] [Abstract][Full Text] [Related]
2. [Effects of matrine on the expression of NKG2D ligands in leukemia cells]. Ma LD; Lu XZ; Zhu ZC; Jiang LJ; Zhou M; Qian SX; Li JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1429-34. PubMed ID: 24370024 [TBL] [Abstract][Full Text] [Related]
3. [Matrine enhances the cytotoxic sensitivity of ABCG2high nasopharyngeal carcinoma cells to natural killer cells by inducing high expression of NKG2D receptor ligands]. Huang YX; Wang Y; Sun M; Zhou XY; Deng L; Guo KY Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1329-32. PubMed ID: 19620045 [TBL] [Abstract][Full Text] [Related]
4. Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia. Lu X; Zhu Z; Jiang L; Sun X; Jia Z; Qian S; Li J; Ma L Am J Transl Res; 2015; 7(10):1838-49. PubMed ID: 26692928 [TBL] [Abstract][Full Text] [Related]
5. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260 [TBL] [Abstract][Full Text] [Related]
6. Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma. Wu X; Tao Y; Hou J; Meng X; Shi J Neoplasia; 2012 Dec; 14(12):1178-89. PubMed ID: 23308050 [TBL] [Abstract][Full Text] [Related]
7. [Growth inhibition effect of matrine on K562 cells mediated by IL-6/JAK/STAT3 signaling pathway]. Ma L; Zhu Z; Sun X; Jiang L; Bai Y; Lu X; Zhou M; Qian S; Li J Zhonghua Xue Ye Xue Za Zhi; 2015 May; 36(5):422-6. PubMed ID: 26031532 [TBL] [Abstract][Full Text] [Related]
8. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection. Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251 [TBL] [Abstract][Full Text] [Related]
9. Matrine suppresses cell growth of human chronic myeloid leukemia cells via its inhibition of the interleukin-6/Janus activated kinase/signal transducer and activator of transcription 3 signaling cohort. Ma L; Zhu Z; Jiang L; Sun X; Lu X; Zhou M; Qian S; Jianyong L Leuk Lymphoma; 2015; 56(10):2923-30. PubMed ID: 25629992 [TBL] [Abstract][Full Text] [Related]
10. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells. Fernández-Messina L; Ashiru O; Agüera-González S; Reyburn HT; Valés-Gómez M J Cell Sci; 2011 Feb; 124(Pt 3):321-7. PubMed ID: 21224393 [TBL] [Abstract][Full Text] [Related]
11. [Effect of Chidamide on the Killing Acitivity of NK Cells Targeting K562 Cells and Its Related Mechanism In Vitro]. Weng LY; Xue L; He CX; Xu QW; Chu CY; Wang YM; Wang XB Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1167-1170. PubMed ID: 32798393 [TBL] [Abstract][Full Text] [Related]
12. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell. Bae DS; Hwang YK; Lee JK Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008 [TBL] [Abstract][Full Text] [Related]
13. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells. Molfetta R; Quatrini L; Capuano C; Gasparrini F; Zitti B; Zingoni A; Galandrini R; Santoni A; Paolini R Eur J Immunol; 2014 Sep; 44(9):2761-70. PubMed ID: 24846123 [TBL] [Abstract][Full Text] [Related]
14. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. Bae JH; Kim JY; Kim MJ; Chang SH; Park YS; Son CH; Park SJ; Chung JS; Lee EY; Kim SH; Kang CD J Immunother; 2010 May; 33(4):391-401. PubMed ID: 20386467 [TBL] [Abstract][Full Text] [Related]
15. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909 [TBL] [Abstract][Full Text] [Related]
16. RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity. Cao W; Xi X; Hao Z; Li W; Kong Y; Cui L; Ma C; Ba D; He W J Biol Chem; 2007 Jun; 282(26):18922-8. PubMed ID: 17470428 [TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study. Lee GH; An HJ; Kim TH; Kim G; Park KS; Park H; Lee TH; Kwon AY Yonsei Med J; 2021 Apr; 62(4):288-297. PubMed ID: 33779082 [TBL] [Abstract][Full Text] [Related]
18. Matrine regulates immune functions to inhibit the proliferation of leukemic cells. Zhang L; Zhang H; Zhu Z; Jiang L; Lu X; Zhou M; Sun X; He L; Bai Y; Ma L Int J Clin Exp Med; 2015; 8(4):5591-600. PubMed ID: 26131142 [TBL] [Abstract][Full Text] [Related]
19. Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895 [TBL] [Abstract][Full Text] [Related]
20. A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2. Uhlenbrock F; van Andel E; Andresen L; Skov S Mol Immunol; 2015 Aug; 66(2):418-27. PubMed ID: 25983110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]